The "neurotic" edema: The parent disease and its offspring

American Journal of Medicine

Volumn 113, Issue 3, 2002, Pages 249-251

  Frank, Michael M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12A; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR; CYTOTOXIC AGENT; DANAZOL; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; KALLIKREIN; KALLIKREIN INHIBITOR; MANNAN BINDING LECTIN; PLASMIN INHIBITOR; PROTEINASE; SERINE PROTEINASE INHIBITOR; TRANEXAMIC ACID;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GASTROINTESTINAL MUCOSA; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNOSTIMULATION; LUPUS ERYTHEMATOSUS; LYMPHOSARCOMA; MONOCLONAL IMMUNOGLOBULINEMIA; PHARYNX; PLASMA; POINT MUTATION; PRIORITY JOURNAL; PROGENY; SHORT SURVEY; STOP CODON; SYMPTOMATOLOGY;

EID: 0037101997     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01227-5     Document Type: Editorial

References (16)

1. Frémeaux-Bacchi V., Guinnepain M.T., Cacoub P., et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med. 113:2002;000-000.
2. Quincke H. Über akutes umschriebenes H autödem. Monatsschr Prakt Dermatol. 1:1882;129-131.
3. Osler W. Hereditary angioneurotic oedema. Am J Med Sci. 95:1888;362-367.
4. Frank M.M., Gelfand J.A., Atkinson J.P. Hereditary angioedema the clinical syndrome and its management . Ann Intern Med. 84:1976;580-593.
5. Landerman N.S., Webster M.E., Becker E.L., Ratcliffe H.E. Hereditary angioneurotic edema. J Allergy. 33:1962;330-341.
6. Donaldson V.H., Evans R.R. A biochemical abnormality in hereditary angioneurotic edema. Am J Med. 35:1963;37-44.
7. Han E.D., MacFarlane R.C., Mulligan A.N., et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest. 109:2002;1057-1063.
8. Davis A.E. III. C1 inhibitor gene and hereditary angioedema. Volanakis J.E., Frank M.M., The Human Complement System in Health and Disease. 1998;455-480 Marcel Dekker, New York, New York.
9. Spaulding W.B. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med. 53:1960;739-745.
10. Gelfand J.A., Sherins R.J., Alling D.W., Frank M.M. Treatment of hereditary angioedema with danazol. N Engl J Med. 295:1976;1444-1448.
11. Caldwell J.R., Ruddy S., Schur P.H., Austen K.F. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1:1972;39-51.
12. Gelfand J.A., Ross G.R., Conley L., et al. Acquired C1 esterase inhibitor deficiency and angioedema a review . Medicine (Baltimore). 58:1979;321-328.
13. Alsenz J., Lambris J.D., Bork K., Loos M. Acquired C1 inhibitor (C1-INH) deficiency type II replacement therapy with C1 INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies . J Clin Invest. 83:1989;1794-1799.
14. He S., Sim R.B., Whaley K. Mechanism of action of anti-C1-inhibitor autoantibodies prevention of the formation of stable C1s-C1-inh complexes . Mol Med. 4:1998;119-128.
15. Cugno M., Cicardi M., Coppola R., Agostoni A. Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. 33:1996;361-364.
16. Marasini B., Cicardi M., Martignoni G.C., Agostoni A. Treatment of hereditary angioedema. Klin Wochenschr. 56:1978;819-823.